CASI PHARMACEUTICALS, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2023-12-31 | $278.00K 20-F · filed 2026-05-15 | |
| 2022-12-31 | $3.27M 20-F · filed 2025-03-31 |